HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system

HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system

Abstract Background European guidelines for cervical cancer screening now recommend the use of clinically validated assays for high-risk HPV-DNA sequences as primary test in women older than 30 years, performed in centralized laboratories, and run on systems providing automated solutions for all ste...

Full description

Bibliographic Details
Main Authors: Helena Frayle, Silvia Gori, Martina Rizzi, Bianca Nives Graziani, Elisa Vian, Paolo Giorgi Rossi, Annarosa Del Mistro
Format: Article
Language:English
Published: BMC 2019-03-01
Series:BMC Women's Health
Subjects:
Cervical cancer screening
HPV testing
Automation
Technical improvement
Clinical performance
Online Access:http://link.springer.com/article/10.1186/s12905-019-0743-0

Internet

http://link.springer.com/article/10.1186/s12905-019-0743-0

Similar Items